Position in NTRA
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$211,459
+$98,665 QoQ
Shares Held
779
+38.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#658
of 846 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $4,878,585 across 26 Diagnostics & Research names. NTRA ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
4,957 | $658,438 | |
| 2 | ILMN |
Illumina, Inc.
|
3,622 | $636,856 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,014 | $533,810 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
1,963 | $445,188 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,291 | $442,667 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
858 | $430,166 | |
| 7 | RVTY |
Revvity, Inc.
|
2,280 | $253,672 | |
| 8 | NTRA |
Natera, Inc.
This page
|
779 | $211,459 |
All Filings in NTRA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,459 | 779 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $112,794 | 564 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $81,785 | 357 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $51,832 | 322 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $56,257 | 333 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $33,372 | 236 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $33,876 | 214 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $6,093 | 48 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $8,230 | 76 | Shares | Sole | 2024-07-08 | |
| 2023-09-30 | $132 | 3 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $145 | 3 | Shares | Sole | 2023-07-10 | |
| No filing history on record for this holder in this stock. | ||||||